HRCI-HRB Joint Funding Scheme 2022-Call for EOI applications

Fighting Blindness are now accepting Expression of Interest (EOI) applications for the HRCI-HRB Joint Funding Scheme.

All proposals to Fighting Blindness must address our research priorities outlined below.

Our research priorities

Fighting Blindness is committed to the development of therapies that are accessible to all patients affected by sight loss and the wide spectrum of retinal degenerative disease through the pursuit and enablement of scientific medical research.

For this co-funding scheme, we are inviting original, internationally-competitive proposals that are relevant to the research priorities of Fighting Blindness and align with one or more of the following research areas:

  • Diagnostics
  • Therapeutics
  • Elucidating molecular mechanisms and/or protective pathways in retinal degenerations
  • Understanding genetic modifiers of retinal disease severity and progression

Cross-disciplinary collaborations that address a clinical need or current knowledge gaps are encouraged. Where applicable, projects must demonstrate a clear translational path to potential intervention.

Funding available

The maximum funding available is €300,000 for 36 month project duration. However projects up to 12 months will also be considered.

Application process

An initial Expressions of Interest (max 2-3 pages) should describe succinctly the following:

  • Overall objectives of the project
  • Current knowledge and research gaps
  • Relevance to goals of Fighting Blindness
  • Implementation of Public and Patient Involvement
  • Duration and Expected costs

Please submit an EOI to by 5pm on Monday 23rd August 2021.

Following review by our Medical and Scientific Advisory Board, a shortlist of successful applicants will be notified for requests for their full application.

Applicants invited to submit a full application will be provided with all relevant documentation.

Documentation including the full application form from previous rounds of the scheme can be found here.


Below is an indicative timeline for the award.

Expression of Interest applications open Tuesday 13th July 2021
Deadline for submission of EOI to Fighting Blindness  5pm Monday 23rd August
Submission of Full Application to Fighting Blindness (if shortlisted) Early November 2021
Right to reply phase Mid-Dec-Mid Jan 2022
Submission of shortlisted applications to HRB Early March 2022

Further information

Further information on the call including eligibility criteria of applicants and project, application process, review process, information on PPI etc. can be found in the HRCI-HRB Instructions to Applicants document.

All proposals must meet the eligibility criteria outlined in the HRCI-HRB Instructions to Applicants document and also address the research priorities of Fighting Blindness.

Information on the HRCI-HRB Joint Funding Scheme can also be found on:


If you have any questions please contact the research department via email on

Related documents to download

Please note the HRCI-HRB Instructions to Applicants document does not contain specific dates. These dates will be officially confirmed by the HRB in September 2021.

Documentation including the full application form from previous rounds of the scheme can be found here.